ArticlePDF Available

Subacute sclerosing panencephalitis presenting as rapidly progressive young-onset dementia

Authors:

Abstract and Figures

Onset of dementia before 65 years of age is termed as young-onset dementia (YOD). Very little literature exists regarding the clinical features and diagnoses of dementia in younger individuals. We present a case series of four patients of age 10 to 23 years with severe dementia within 18 months of clinical onset (rapidly progressive dementia). Three patients had generalised periodic complexes typical of subacute sclerosing panencephalitis (SSPE) on electroencephalogram (EEG). All patients had elevated cerebrospinal fluid (CSF) IgG measles antibodies. Our case series highlights that SSPE is an important cause of rapidly progressive YOD in developing countries like India.
Content may be subject to copyright.
Abstract
Onset of dementia before 65 years of age is termed as
young-onset dementia (YOD). Very little literature exists
regarding the clinical features and diagnoses of dementia
in younger individuals. We present a case series of four
patients of age 10 to 23 years with severe dementia within
18 months of clinical onset (rapidly progressive dementia).
Three patients had generalised periodic complexes typical
of subacute sclerosing panencephalitis (SSPE) on
electroencephalogram (EEG). All patients had elevated
cerebrospinal fluid (CSF) IgG measles antibodies. Our case
series highlights that SSPE is an important cause of rapidly
progressive YOD in developing countries like India.
Keywords: Young-onset dementia, Subacute sclerosing
panencephalitis, Electroencephalogram.
Introduction
Subacute sclerosing panencephalitis (SSPE) is caused by a
mutated measles virus and is characterised by cognitive
deterioration, motor decline and myoclonus.
1
The onset is
between 5 and 15 years of age with a progressive
downhill course leading to death within two to four years.
Though the incidence of SSPE has declined substantially
after the introduction of an effective measles vaccine, the
annual incidence of SSPE is still quite high but variable in
developing countries.
2
Rapidly progressive global
cognitive decline leading to severe dementia or death is a
frequent presentation of SSPE. Severe dementia or death
within 18 months of clinical onset is termed rapidly
progressive dementia.
3
We present a profile of four
patients of SSPE presenting as rapidly progressive young-
onset dementia (RP-YOD). SSPE is an important cause of
RP-YOD in developing countries as opposed to other
causes seen in the developed countries.
Case-1
A 23-year-old carpenter presented with progressive
cognitive decline for the preceding two years, change in
personality since one year, disinhibited behaviour since
six months and getting lost in familiar surroundings since
three months. The patient was in his usual state of health
two years ago when his relatives noticed that he had
become apathetic, did not interact with relatives and had
become inattentive. He was not able to calculate money
and render appropriate change. He could not use tools
and, hence, was not able to work and had given up his job.
There were episodes when he would come out of the
bathroom without clothes. Before presenting, he was not
able to reach his home and was found wandering in the
market. There was no history of forgetfulness, language
disturbances, delusions, hallucinations, myoclonic jerks,
Vol. 63, No. 7, July 2013
921
CASE SERIES
Subacute sclerosing panencephalitis presenting as rapidly
progressive young-onset dementia
Rahul Tryambak Chakor, Nandanavana Subbareddy Santosh
Department of Neurology, Topiwala National Medical College, BYL Nair
Charitable Hospital, Mumbai Central, Mumbai, India.
Correspondence: Rahul Tryambak Chakor. Email: drchakorrt@yahoo.com.in
Figure-1: Flair axial magnetic resonance imaging of Case-1 showing confluent
symmetrical white mater hyperintensity in bilateral periventricular region reaching up
to the subcortical regions. It appears equally predominant in the anterior as well as
posterior regions. The ventricles appear a little prominent.
fever, headache, vomiting or head injury. There was no
family history of similar complaints. He had measles at
four years of age and had not received any vaccination.
His general physical examination was unremarkable.
Higher mental function (HMF) examination revealed poor
attention, impaired abstract thinking and judgment. Mini-
mental status examination (MMSE) score was 16/30 (lost
six points in orientation, five in calculations, and one point
each in reading, writing and construction). Frontal
assessment battery (FAB) score was 8/18 (lost three points
each in similarities and lexical fluency, one point each in
motor programming and conflicting instructions, and two
points in go-no go test). He had difficulty in clock drawing.
There was ideational and ideomotor apraxia. He had
alexia, agraphia, acalculia but no finger agnosia,
prosopagnosia, or visual agnosias. Cranial nerve
examination revealed right hemianopia. Rest of the
neurologic examination was normal. Magnetic resonance
imaging (MRI) of the brain revealed symmetric T2 and Flair
hyper-intense areas in the bilateral frontal and parieto-
occipital white matter (Figure-1). Electroencephalogram
(EEG) showed periodic lateralised epileptiform discharges
(PLEDs) from the left temporo-parietal region (Figure-2).
Cerebrospinal fluid (CSF) IgG measles antibody was 4.350
IU /ml (N < 0.08).
Case-2
A 14-year-old student presented with deteriorating
school performance for three months, and aggressive
behaviour and getting lost in familiar environment since
one month. The patient was apparently normal three
months earlier when the teachers noticed deteriorating
scholastic performance. He could not do arithmetic
calculations, and was not able to answer simple
questions. He was not able to grasp lessons taught in the
class. Once he had lost way while going to school. His
friends complained that he had become aggressive and
would quarrel on petty issues. He used to forget where his
books were kept and had difficulty in passing on the
messages told to him. There was no history of language
disturbances, delusions, hallucinations, myoclonic jerks,
fever, headache, vomiting or head injury. There was no
family history of similar complaints. He had received
measles immunisation and did not have measles.
HMF examination revealed poor attention, impaired
abstract thinking and judgement. MMSE score was 14/30
(lost seven points in orientation, four points in calculation,
three points in recall, and one point each in construction
and writing). FAB score was 3/18 (lost three points each in
similarities, lexical fluency, motor programming,
conflicting instructions & go-no go test). Rest of the
neurological examination was normal. EEG showed
periodic discharges of slow waves intermixed with sharp
waves of 1-2 seconds' duration every 10 seconds without
clinical myoclonus (Figure-3). MRI of the brain was normal.
CSF IgG measles antibody was 4.88 IU /ml.
Case-3
An 18-year-old girl presented with apathetic behaviour
for six months, disinhibited behaviour and myoclonus
since three months. She was apparently normal six
months earlier when it was noticed that she had become
less interested in going to work and in doing household
chores. She was apathetic, less talkative and less
interactive with family members. Three months later, she
developed sudden jerky movements of hands with
objects dropping, and sudden turning of the head
occurring at regular intervals several times a minute.
Subsequently, she developed disinhibited behaviour and
inappropriate micturition. There was no family history of
J Pak Med Assoc
922 R. T. Chakor, N. S. Santosh
Figure-2: Electroencephalogram of Case-1 showing periodic lateralised epileptiform
discharges from the left temporo-parietal region.
Figure-3: Electroencephalogram of Case-2 showing periodic complexes of slow waves
intermixed with sharp waves every 10 seconds.
similar complaints. There was no history of forgetfulness,
language disturbances, delusions, hallucinations, fever,
headache, vomiting or head injury. She had measles at the
age of two, and had not received any vaccination.
HMF examination revealed poor attention span, impaired
judgement and abstract thinking. MMSE score was 8/30
(lost nine points in orientation, three points in recall, five
points in calculation, one point each in reading, writing
and construction, and two points in three-stage
command). FAB score was 2/18 (lost three points each in
similarities, lexical fluency, motor programming,
conflicting instructions go-no go and one point in
prehension behaviour). Other detailed lobar functions
could not be performed due to poor attention span. Rest
of the neurological examination was normal. She had
myoclonus time locked with EEG paroxysms of periodic
complexes of slow waves intermixed with sharp waves
every 5 seconds (Figure-4). MRI brain showed T2
hyperintensities in bilateral frontal and fronto-parietal
cortical and subcortical regions. CSF IgG measles
antibodies were 4.693 IU/ml.
Case-4
A 10-year-old boy presented with deteriorating school
performance for eight months, apathetic behaviour,
muttering to self, getting lost in familiar environment and
myoclonus since the preceding six months. He was
apparently normal eight months earlier, when it was
noticed that his school performance had deteriorated and
he could not answer simple mathematics which he was
able to do so earlier. The teachers also complained that he
was less attentive. Over the next two months, he became
less interested in going to school and used to get lost
while going to school. He became apathetic, used to
remain aloof and was found muttering to self. There was
no history of language disturbances, delusions,
hallucinations, fever, headache, vomiting or head injury.
There was no family history of similar complaints. He had
measles at the age of two, and had not received any
vaccination.
On examination, attention and comprehension were
severely impaired for detailed HMF testing and MMSE.
FAB score was 2/18 (lost three points each in similarities,
lexical fluency, motor programming, conflicting
instructions, go-no go and one point in prehension
behaviour). There were bilateral pyramidal signs on motor
examination. Rest of the neurological examination was
normal. He had myoclonus time locked with EEG
paroxysms of slow waves intermixed with sharp waves
every 3.5 to 4 seconds. On MRI brain, there were T2
hyperintensities in the right temporo-occipital and right
posterior parietal regions. CSF IgG measles antibodies
were 4.909 IU/ml.
Discussion
All the patients had rapidly progressive cognitive decline
with predominant frontal lobe dysfunction. Case 1
presented with cognitive decline interfering with his work;
cases 2 and 4 had deteriorating school performance; and
case 3 had initial apathetic behaviour followed by
disinhibited behaviour. All patients had an RP-YOD with
onset between 10 to 23 years of age (mean age 16.25±5.56
years). There was no family history of similar complaints.
Three of the four patients (75%) had history of measles and
only one (25%) patient had received immunisation. Three
(75%) patients had EEG with generalised periodic
complexes of slow waves intermixed with sharp waves
every 3 to 10 seconds characteristic of SSPE. Case one had
PLEDs, which are not specific to SSPE. Periodic complexes
in SSPE may be grossly asymmetrical and resemble PLEDs
in some montages. All patients had elevated CSF IgG
measles antibodies.
Vol. 63, No. 7, July 2013
Subacute sclerosing panencephalitis presenting as rapidly progressive young-onset dementia 923
Figure-4: Electroencephalogram of Case-3 showing periodic complexes of slow waves
intermixed with sharp waves every 6 to 7 seconds.
Figure-5: Electroencephalogram of Case-4 showing periodic complexes of slow waves
intermixed with sharp waves every 3 seconds.
Conventionally, dementia with onset before 65 years of
age is regarded as young-onset dementia (YOD).
4
Very
little literature exists regarding the clinical features and
diagnoses in younger individuals experiencing rapidly
progressive dementia, primarily due to the rarity of the
presentation. In a study of RP-YOD by Kelley et al, the age
of onset and presentation of dementia was after 20 years
of age.
3
There was no case of SSPE in their study. In
another study of YOD with onset between 17-45 years
Kelley et al found that the cause of dementia varied with
age with inborn errors of metabolism being more
common before age 30 years, and neurodegenerative
aetiologies being more common after age 35.
5
In their
study, the aetiology of YOD was neurodegenerative in
31.1%, autoimmune or inflammatory in 21.3%,
metabolic in 10.6%, unknown in 18.7% and infectious in
4.7%. Prion disease,
6
human immunodeficiency virus
(HIV) dementia,
3
progressive multifocal
leukoencephalopathy
2
were the various infectious
aetiologies.
5
They did not have any case of SSPE as a
cause of YOD. Our case series highlights that SSPE is an
important cause of YOD, especially RP-YOD, in
developing countries like India.
The existence of the SSPE in high number in India could
be multifactorial improper vaccine coverage, failure of
cold chain maintenance or circulating atypical measles
virus strain can be the causes.
6
It is notable that only one
patient in this series had received immunisation.
Conclusion
In developing countries, RP-YOD should alert one for the
possibility of SSPE. Non-immunisation is an important
factor for the existence of SSPE in developing countries.
References
1. Prashanth LK, Taly AB, Ravi V, Sinha S, Arunodaya GR. Adult onset
subacute sclerosing panencephalitis: clinical profile of 39 patients
from a tertiary care centre. J Neurol Neurosurg Psychiatry 2006;
77: 630-3.
2. Garg RK. Subacute sclerosing panencephalitis. Postgrad Med J
2002; 78: 63-70.
3. Kelley BJ, Boeve BF, Josephs KA. Rapidly progressive young-onset
dementia. Cogn Behav Neurol 2009; 22: 22-7.
4. Rossor MN, Fox NC, Mummery CJ, Schott JM, Warren JD. The
diagnosis of young-onset dementia. Lancet Neurol 2010; 9: 793-
806.
5. Kelley BJ, Boeve BF, Josephs KA. Young-onset dementia:
demographic and etiologic characteristics of 235 patients. Arch
Neurol 2008; 65: 1502-8.
6. Mishra B, Kakkar N, Ratho RK, Singhi P, Prabhakar S. Changing
trend of SSPE over a period of ten years. Indian J Public Health
2005; 49: 235-7.
J Pak Med Assoc
924 R. T. Chakor, N. S. Santosh
... Although these findings are typical in advanced SSPE, the complete absence of myoclonic jerks throughout the illness, presentation in the third decade, absence of characteristic imaging and EEG findings were unusual. Chakor and Santosh [4] published a series of four cases of SSPE that presented with rapidly progressive dementia in young adults aged between 18 and 23 years. One of their cases had no periodic complexes as well. ...
... Although these findings are typical in advanced SSPE, the complete absence of myoclonic jerks throughout the illness, presentation in the third decade, absence of characteristic imaging and EEG findings were unusual. Chakor and Santosh [4] published a series of four cases of SSPE that presented with rapidly progressive dementia in young adults aged between 18 and 23 years. One of their cases had no periodic complexes as well. ...
... SSPE most commonly presents several years after initial infection with wild-type measles virus, with a slowly progressive course. In rare instances, it may present as acute encephalitis, with a rapidly progressive course, leading to death within months [27], or as rapidly progressive dementia [28]. Such cases are usually classified as measles inclusion body encephalitis (see below). ...
Article
Full-text available
Purpose of Review Owing to vaccine hesitancy, there has been a resurgence of measles infections in developed countries. Practitioners can expect to see an increase in patients with neurologic complications of measles. These devastating disorders include primary measles encephalitis, acute post measles encephalitis, subacute sclerosing panencephalitis (SSPE), and measles inclusion body encephalitis (MIBE). Recent Findings Although there are many unanswered questions regarding the neurologic complications of measles, recent advances have led to better understanding of the mechanism of the spread of measles within the nervous system, particularly the disruption of F protein function, which raises the possibility of treatment with fusion-inhibiting molecules. Summary Measles and its neurological complications are preventable and must be prevented. Neurologists must educate other clinicians and the public regarding the consequences of inadequate herd immunity to measles. More effective treatments for SSPE and MIBE may be available in the near future, but currently these remain lethal diseases.
... The disease is characterized by seizures, myoclonus, ataxia, be- havioral and personality changes, extrapyramidal dysfunctions and vision problems. In the literature SSPE cases presenting with psychiatric symptoms such as first episode schizophrenia, young-onset dementia were rarely reported [2,6,7,8,9,10,11]. It mostly occurs during childhood and early adolescence. ...
... Vision loss (4-posterior visual pathway; 2-maculopathy) was associated in 6 (37.5%) patients. Though none of the aforementioned RPD series or the young onset dementia series by Kelly et al. [19] had SSPE as a cause, there are case reports with SSPE presenting with dementia [20,21]. The higher proportion of cases with SSPE in our series could be due to improper immunisation, failure of cold chain maintenance or circulating atypical measles virus strain. ...
Article
Full-text available
Background and purpose Rapidly progressive dementia (RPD) is an emergency in cognitive neurology, defined as cognitive impairment affecting the daily living activities developed over less than 1 year. This study investigated the profile of patients with rapidly progressive dementia at first presentation. Methods Retrospective case analysis was done in 187 patients with rapidly progressive dementia who presented to the Postgraduate Institute of Medical Education and Research, Chandigarh, India from January 2008 to August 2016. Patients were divided into three groups: (1) Reversible (treatable) secondary dementia group, (2) Prion dementia group (sporadic Creutzfeldt-Jakob disease), (3) Non-prion Neurodegenerative and vascular dementias (primary neurodegenerative and vascular dementia). Cases presenting with delirium secondary to metabolic, drug induced or septic causes and those with signs of meningitis were excluded. Results Secondary reversible causes formed the most common cause for RPD with immune mediated encephalitides, neoplastic and infectious disorders as the leading causes. The patients in this series had an younger onset of RPD. Infections presenting with RPD accounted for the most common cause in our series (39%) with SSPE (41%) as the leading cause followed by neurosyphilis (17.9%) and progressive multifocal leukoencephalopathy (15.3%). Immune mediated dementias formed the second most common (18.1%) etiologic cause for RPD. The neurodegenerative dementias were third common cause for RPD in our series. Neoplastic disorders and immune mediated presented early (< 6 months) while neurodegenerative disorders presented later (> 6 months). Conclusions Rapidly progressive dementia is an emergency in cognitive neurology with potentially treatable or reversible causes that should be sought for diligently.
... The disease is characterized by seizures, myoclonus, ataxia, be-havioral and personality changes, extrapyramidal dysfunctions and vision problems. In the literature SSPE cases presenting with psychiatric symptoms such as first episode schizophrenia, young-onset dementia were rarely reported [2,6,7,8,9,10,11]. It mostly occurs during childhood and early adolescence. ...
Article
Full-text available
Subacute Sclerosing Panencephalitis (SSPE) is the late complication of measles and is characterized by seizures, myoclonus, ataxia, behavioral and personality changes, extrapyramidal dysfunctions and vision problems. A 19 year old female patient with SSPE who was followed up at psychiatry clinic with the diagnosis of atypical psychotic disorder was presented. While psychiatric signs and symptoms were dominant, she was diagnosed as SSPE.
... Considering its large clinical spectrum, SSPE appeared as a reasonable diagnostic option (possible SSPE) in all patients with otherwise unexplained new onset psychiatric, behavioral, cognitive, neurological, and visual problems whereas typical EEG findings or myoclonics may be strongly supportive. [32][33][34] Finally, the diagnosis is established (proven SSPE) by the presence of typical clinical findings combined with either a high measles antibody index that proves a strong intrathecal immune response to MV or a positive brain histopathology. 35 Brain histopathology, the former diagnostic method of choice, may be restricted to exceptional cases where the diagnosis cannot be confirmed by other methods. ...
Article
Full-text available
Subacute sclerosing panencephalitis (SSPE) is a chronic infection of the central nervous system caused by the measles virus (MV). Its prevalence remains high in resource poor countries and is likely to increase in the Northern Europe as vaccination rates decrease. Clinical knowledge of this devastating condition, however, is limited. We therefore conducted this multinational survey summarizing experience obtained from more than 500 patients treated by 24 physicians in seven countries. SSPE should be considered in all patients presenting with otherwise unexplained acquired neurological symptoms. In most patients, the diagnosis will be established by the combination of typical clinical symptoms (characteristic repetitive myoclonic jerks), a strong intrathecal synthesis of antibodies to MV and typical electroencephalogram findings (Radermecker complexes). Whereas the therapeutic use of different antiviral (amantadine, ribavirin) and immunomodulatory drugs (isoprinosine, interferons) and of immunoglobulins has been reported repeatedly, optimum application regimen of these drugs has not been established. This is partly due to the absence of common diagnostic and clinical standards focusing on neurological and psychosocial aspects. Carbamazepine, levetiracetam, and clobazam are the drugs most frequently used to control myoclonic jerks. We have established a consensus on essential laboratory and clinical parameters that should facilitate collaborative studies. Those are urgently needed to improve outcome. Georg Thieme Verlag KG Stuttgart · New York.
Article
Full-text available
Subacute sclerosing panencephalitis (SSPE) is a progressive neurological disorder of childhood and early adolescence. It is caused by persistent defective measles virus. Brain biopsies or postmortem histopathological examination show evidence of astrogliosis, neuronal loss, degeneration of dendrites, demyelination, neurofibrillary tangles, and infiltration of inflammatory cells. Patients usually have behavioral changes, myoclonus, dementia, visual disturbances, and pyramidal and extrapyramidal signs. The disease has a gradual progressive course leading to death within 1-3 years. The diagnosis is based upon characteristic clinical manifestations, the presence of characteristic periodic EEG discharges, and demonstration of raised antibody titre against measles in the plasma and cerebrospinal fluid. Treatment for SSPE is still undetermined. A combination of oral isoprinosine (Inosiplex) and intraventricular interferon alfa appears to be the best effective treatment. Patients responding to treatment need to receive it life long. Effective immunisation against measles is the only solution presently available to the problem of this dreaded disease.
Article
Full-text available
Clinical and laboratory characteristics of 39 patients with adult onset subacute sclerosing panencephalitis (SSPE) are described and compared to those of juvenile onset patients regarding preceding measles, age at onset, gender, interval between onset and diagnosis, clinical profile, and course during follow up. Diagnosis was based on clinical and electroencephalographic findings and raised anti-measles antibody titres in cerebrospinal fluid. Mean age at SSPE symptom onset was 20.9+/-4.9 years and mean interval from onset to diagnosis was 6.3+/-9.6 months. Referral diagnosis was accurate in only 12 patients. Presenting symptoms included myoclonus, behavioural changes, seizures, and cognitive, visual, and extrapyramidal disturbance. All patients received symptomatic therapy; 19 also received disease modifying agents. Five of seven pregnant women had successful deliveries. The follow-up period varied widely (maximum 60 months, median 9 months). The profile of adult onset SSPE did not differ from the rest of the cohort, except for a longer interval between measles infection and symptom onset (p<0.0001). SSPE in adults poses diagnostic challenges for clinicians. A high index of suspicion and appropriate investigations are necessary for early diagnosis and counselling.
Chapter
This article has no abstract.
Article
A diagnosis of dementia is devastating at any age but diagnosis in younger patients presents a particular challenge. The differential diagnosis is broad as late presentation of metabolic disease is common and the burden of inherited dementia is higher in these patients than in patients with late-onset dementia. The presentation of the common degenerative diseases of late life, such as Alzheimer's disease, can be different when presenting in the fifth or sixth decade. Moreover, many of the young-onset dementias are treatable. The identification of causative genes for many of the inherited degenerative dementias has led to an understanding of the molecular pathology, which is also applicable to later-onset sporadic disease. This understanding offers the potential for future treatments to be tailored to a specific diagnosis of both young-onset and late-onset dementia.
Article
To characterize a cohort of individuals who have experienced rapidly progressive dementia with onset before age 45. Very little data regarding the clinical features or clinical spectrum of rapidly progressive young-onset dementia (RP-YOD) is available, primarily consisting of case reports or small series. A search of the Mayo Clinic medical record was employed to identify patients who had onset before age 45 of rapidly progressive dementia. All available medical records, laboratory data, neuroimaging studies, and pathologic data were reviewed. Twenty-two patients met the predefined inclusion and exclusion criteria. Behavioral and affective disorders, cerebellar dysfunction, and visual and/or oculomotor dysfunction were common early clinical features within the cohort, as were clinical features often associated with Creutzfeldt-Jakob disease. Diagnostic testing identified an etiology in most patients. Presentations of RP-YOD result from a variety of etiologies and significant overlap in clinical features is observed. Clinical features often associated with Creutzfeldt-Jakob disease seem to be common within the entire cohort of RP-YOD patients. Diagnostic studies aided in establishing a diagnosis in most patients, however 5 had uncertain diagnoses despite exhaustive evaluation.
Article
Onset of dementia before age 45 years presents a difficult clinical circumstance, having a broad differential diagnosis and numerous psychosocial implications for the patient and their family. Few data exist regarding the demographics characterizing this population or the etiologic diagnoses among those affected. To characterize the demographic characteristics and the etiologic causes of dementia with age at onset younger than 45 years. Observational, retrospective, single-cohort study. Multispecialty group academic medical center. We searched the Mayo Clinic Rochester electronic Medical Record Linkage System to identify individuals who were seen for evaluation of progressive cognitive decline between the ages of 17 and 45 years from January 1996 through December 2006. This search identified 235 individuals who met the established inclusion and exclusion criteria. All available clinical, laboratory, magnetic resonance imaging, and pathological data were reviewed. Causes varied, with neurodegenerative etiologies accounting for 31.1% of the cohort; Alzheimer disease was uncommon. Autoimmune or inflammatory causes accounted for 21.3%. At last follow-up, 44 patients (18.7%) had an unknown etiology, despite exhaustive evaluation. Cause varied with age, with inborn errors of metabolism being more common before age 30 years and with neurodegenerative etiologies being more common after age 35 years. Young-onset dementia (age at onset, <45 years) includes a broad variety of etiologies, with few patients having a potentially treatable disorder. The etiologic spectrum and the relative percentages of patients within etiologic groups differed in important ways from existing reports of early-onset dementia (ie, age at onset, <65 years).
Article
Sub acute sclerosing pan-encephalitis (SSPE) is a slowly progressive inflammatory disorder of the central nervous system. A decline in frequency has been noticed in most of the developed countries, whereas it continues to be high in developing countries. Though a number of studies have been carried out, the exact trend of SSPE is still not clear. Hence the present study was carried out to analyze the trend of SSPE over the past ten years in and around Chandigarh. A total of 205 patients with clinical features suggestive of SSPE were enrolled for the study during Jan'92 to Dec. 2001. Measles specific antibodies were detected in blood and CSF by HAI method. 114 patients were found to be positive for measles specific HAI antibody with a male preponderance. The number of SSPE cases were found to be more during the period 1992-95 in comparison to the next 6 years (p < 0.05). The high incidence of SSPE in our country could be due to improper vaccine coverage, poor cold chain maintenance or circulation of atypical measles virus strain.
The diagnosis of young-onset dementia
  • Mn Rossor
  • Nc Fox
  • Cj Mummery
  • Jm Schott
  • Jd Warren
Rossor MN, Fox NC, Mummery CJ, Schott JM, Warren JD. The diagnosis of young-onset dementia. Lancet Neurol 2010; 9: 793806.